Rising energy, freight, and supply chain expenses are escalating seafood prices globally. Governments offer aid, but it's stretched thin, i...

Fuel prices are volatile, electricity tariffs are rising, and your LPG cylinder is at the mercy of global events. Here’s how switching to a...

Is Thailand-based ⁠OBON ⁠Corp really 'Company-1', and were Nvidia chips sent to Alibaba? A new report says the US suspects AI servers with ...

China is rapidly adopting artificial intelligence tools. Ordinary citizens and businesses are using AI for daily tasks and work. Chinese co...

Super Micro is investigating an indictment against three individuals for export-control violations. The company is also reviewing its trade...

The Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made b...

US and China officials met in Kuala Lumpur to prevent trade war escalation ahead of Trump-Xi talks. Discussions focus on tariffs, technolog...

Long-term structural growth potential driven by anticipated shortage and price increases prompted investors to shuffle their bets in favour...

Jaishankar, who is on a three-day visit to Mexico and his first to the Latin American country as the External Affairs Minister, on Tuesday ...

Wei Sun (49), who was employed in Tucson for 10 years as an electrical engineer with Raytheon Missiles and Defense, had earlier pleaded gui...

In 1997, the apex court had said that in case of any ambiguity in a tax exemption provision or notification, it must be interpreted so as t...

To a separate query, she said India is considered as a leading exporter and holds second position in export of generic drugs in terms of vo...

The US is the largest market for domestic generic companies, contributing 25-55% of revenues for large companies, while India supplies arou...

Undoing of regulatory tangles in Ranbaxy may prove to be challenging for Sun Pharma’s Dilip Shangvi. Here are 5 biggest things Sun needs to...

Higher export realisations would help to enhance the overall performance of many companies in the sector for the current September quarter.

Though y-o-y comparison in case of its overseas business has been rendered unviable, the company has showed improved performance in this bu...

Top pharma companies are expected to log a modest double-digit growth in revenues, but flat growth in net profit for the quarter ended June...